Asia Pacific Eubiotics Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 1.89 Billion |
| Market Size (2029) | USD 2.77 Billion |
| CAGR (2024 - 2029) | 8.00 % |
| Market Concentration | High |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Asia Pacific Eubiotics Market Analysis
The Asia Pacific Eubiotics Market size is estimated at USD 1.89 billion in 2024, and is expected to reach USD 2.77 billion by 2029, at a CAGR of 8% during the forecast period (2024-2029).
Eubiotics play a vital role in enhancing animal health, immunity, and overall well-being. This has led to increased demand for eubiotics to improve animal productivity and reduce mortality rates. Furthermore, the ban on Antibiotic Growth Promoters in animal feed is driving the adoption of eubiotics as an alternative in the livestock and poultry industries. In 2023, the World Organisation for Animal Health (WOAH) urged its members to limit antimicrobial use to veterinary medical purposes and to engage in discussions with relevant stakeholders to implement a complete ban on antimicrobials as growth promoters.
The increasing population and rising income levels in countries like India are fueling the demand for meat and animal products, consequently driving the need for quality animal nutrition and eubiotics. According to Invest India, India ranks as the 5th largest meat producer globally, with a production of 9.77 million metric tons in 2022-2023, representing a 5.13% increase from the previous financial year. Furthermore, advancements in eubiotics formulations and delivery methods, particularly through precision nutrition, have enhanced their effectiveness, promoting wider adoption in the market.
Asia Pacific Eubiotics Market Trends
Rapid Growth of the Livestock and Aquaculture Industry
The growth of livestock and aquaculture industries in the Asia-Pacific region is increasing the demand for feed additives, including eubiotics. According to the 2023 World Organisation for Animal Health (WOAH) report on China's livestock census data, pigs constitute 51% of the total livestock population.
The region's aquaculture sector is experiencing rapid growth due to recent government policies. In India, the Ministry of Fisheries, Animal Husbandry, and Dairying implemented the Pradhan Mantri Matsya Sampada Yojana (PMMSY), providing financial assistance for fishing infrastructure and credit-linked subsidies to fish farmers. As a result, India's fish production has increased significantly. The Department of Fisheries reported that in FY 2022-23, the country produced 175.45 lakh metric tons of fish, ranking third globally in fish production.
The increasing meat consumption in the region is also contributing to market growth. According to the Australian Bureau of Statistics, the value of poultry slaughtered in 2023 reached USD 2.56 billion, a 7.6% increase from the previous year's value of USD 2.37 billion.
China to Dominate the Eubiotics Market
China holds a significant position in the global feed probiotics industry, accounting for approximately half of the revenue share in the Asia-Pacific market. The production of eubiotics, particularly probiotics for the aquaculture industry, is a flourishing sector in China. Lactobacillus is the predominant probiotic bacteria used in the Chinese aquafeed industry. The country's expanding meat production, driven by the need to feed its large domestic population, is a key factor propelling the market. In 2022, China's meat production reached around 90 million metric tons, marking the country's highest production level and representing one-quarter of the global total meat production.
China's population consumes pork more frequently than other meats, driving the demand for eubiotics in swine feed. In 2023, China achieved a record-breaking pork production of 57.94 million metric tons, a 4.6% increase from the previous year, according to the National Bureau of Statistics of China. Feed companies are expanding their eubiotics distribution in the country to meet this growing demand. For example, in 2023, Novus International, Inc. partnered with Co-Innova Animal Nutrition Technology (Shanghai) Co., Ltd. to distribute its products in China, including ACTIVATE DA, an organic acid-based nutritional feed additive for pigs.
Asia Pacific Eubiotics Industry Overview
The market studied is fragmented in nature with many companies operating in the market. The major players in the market are Novonesis Group, IFF (Danisco Animal Nutrition & Health), dsm-firmenich, and Bluestar Adisseo Company. The strategic developments include partnerships, expansions, and mergers that aides the growth of the market.
Asia Pacific Eubiotics Market Leaders
-
Novonesis Group
-
IFF (Danisco Animal Nutrition & Health
-
dsm-firmenich
-
Bluestar Adisseo Company
-
Evonik Industries AG
*Disclaimer: Major Players sorted in no particular order
Asia Pacific Eubiotics Market News
- March 2024: Evonik China and Shandong Vland Biotech established a joint venture in Qingdao, China. This partnership focuses on providing biosolutions, including probiotics for animal gut health, to the feed industry. The venture utilizes Vland's production facility to develop innovative solutions and expand the distribution of probiotic products (Ecobiol, Fecinor, GutPlus, and GutCare) in the Chinese market.
- January 2024: Evonik introduced Ecobiol Plus to the Indian market at the Poultry India 2023 Expo in Hyderabad. Ecobiol Plus is a feed probiotic containing Bacillus amyloliquefaciens CECT 5940, designed to maintain intestinal microbial balance in poultry, swine, and aquaculture.
Asia Pacific Eubiotics Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Growth of the Livestock and Aquaculture Industry
4.2.2 Increasing Focus on Animal Health and Welfare
4.2.3 Rising Demand For Sustainable and Natural Feed Additives
4.3 Market Restraints
4.3.1 Lack of Standardization and Regulatory Challenges
4.3.2 High Cost of Production is Limiting the Market
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Powers of Buyers
4.4.2 Bargaining Powers of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitutes
4.4.5 Competitive Rivalry
5. MARKET SEGMENTATION
5.1 Type
5.1.1 Probiotics
5.1.1.1 Lactobacilli
5.1.1.2 Bifidobacteria
5.1.1.3 Other Probiotics
5.1.2 Prebiotics
5.1.2.1 Inulin
5.1.2.2 Fructo-Oligosaccharides
5.1.2.3 Galacto-Oligosaccharides
5.1.2.4 Other Prebiotics
5.1.3 Organic Acids
5.1.4 Essential Oils
5.2 Geography
5.2.1 Asia-Pacific
5.2.1.1 China
5.2.1.2 India
5.2.1.3 Indonesia
5.2.1.4 Thailand
5.2.1.5 Japan
5.2.1.6 South Korea
5.2.1.7 Australia
5.2.1.8 Rest of Asia-Pacific
6. COMPETITIVE LANDSCAPE
6.1 Most Adopted Strategies
6.2 Market Share Analysis
6.3 Company Profiles
6.3.1 Church & Dwight (Arm & Hammer Animal and Food Production)
6.3.2 Novonesis Group
6.3.3 Lallemand, Inc.
6.3.4 IFF (Danisco Animal Nutrition & Health)
6.3.5 dsm-firmenich
6.3.6 Marubeni Corporation (Orffa)
6.3.7 Mitsui & Co., Ltd. and Nippon Soda Co., Ltd. (Novus International, Inc.)
6.3.8 Kemin Industries, Inc.
6.3.9 Associated British Foods (AB Vista)
6.3.10 Vetoquinol
6.3.11 Bluestar Adisseo Company
6.3.12 Evonik Industries AG
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Asia Pacific Eubiotics Industry Segmentation
Feed eubiotics are commercially manufactured feed additives used to enhance livestock performance metrics such as weight gain, feed conversion ratio, and feed intake when administered in appropriate proportions. This study focuses solely on feed eubiotics incorporated into commercial compound feed production. The market is segmented by type (probiotics, prebiotics, organic acids, and essential oils) and by geography (China, India, Indonesia, Thailand, Japan, South Korea, Australia, and Rest of Asia-Pacific).
| Type | ||||||
| ||||||
| ||||||
| Organic Acids | ||||||
| Essential Oils |
| Geography | ||||||||||
|
Asia Pacific Eubiotics Market Research FAQs
How big is the Asia Pacific Eubiotics Market?
The Asia Pacific Eubiotics Market size is expected to reach USD 1.89 billion in 2024 and grow at a CAGR of 8% to reach USD 2.77 billion by 2029.
What is the current Asia Pacific Eubiotics Market size?
In 2024, the Asia Pacific Eubiotics Market size is expected to reach USD 1.89 billion.
Who are the key players in Asia Pacific Eubiotics Market?
Novonesis Group, IFF (Danisco Animal Nutrition & Health, dsm-firmenich, Bluestar Adisseo Company and Evonik Industries AG are the major companies operating in the Asia Pacific Eubiotics Market.
What years does this Asia Pacific Eubiotics Market cover, and what was the market size in 2023?
In 2023, the Asia Pacific Eubiotics Market size was estimated at USD 1.74 billion. The report covers the Asia Pacific Eubiotics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Asia Pacific Eubiotics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Asia Pacific Eubiotics Industry Report
Statistics for the 2024 Asia Pacific Eubiotics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia Pacific Eubiotics analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
Asia Pacific Eubiotics Market Report Snapshots
